*Rhythm Pharmaceuticals Announces MHLW Approval Of IMCIVREE(R) (setmelanotide) For Patients With Acquired Hypothalamic Obesity (HO) In Japan >RYTM

Dow Jones · 3d ago

Please log in to view news